Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Merck Serono and EPFL Announce Research Partnership in Neuroscience, Oncology and Drug Delivery

Abstract:
Three Merck Serono-Endowed Chairs Will be Created at EPFL

Merck Serono and EPFL Announce Research Partnership in Neuroscience, Oncology and Drug Delivery

GENEVA, Switzerland | Posted on October 31st, 2007

Merck Serono and EPFL Open a Major Research Fund

Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced today the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.

Merck Serono will make a total donation of CHF 12.5 million for the Chairs. The professors heading the Merck Serono Chairs will be hired in a way consistent with the quality standards of EPFL.

"We are very pleased to be partnering with one of the world-renowned places of scientific and technical expertise," said Elmar Schnee, President of Merck Serono. "Our collaboration will contribute to the advancement of basic research in areas of high unmet medical needs, such as Neuroscience and Oncology, and to the improvement of drug delivery methods to more effectively treat patients with existing and new medicines. This collaboration will promote the general excellence of the Lake Geneva region in life sciences."

In order to develop the scope of collaboration at the highest academic level and open major perspectives in terms of new therapies and medical applications, Merck Serono will also open a research fund at EPFL of up to CHF 3 million per year over five years.

"This partnership is a great win-win situation", said EPFL President Patrick Aebischer. "It will allow EPFL researchers to participate in the development of drugs for serious human conditions such as cancer and neurodegenerative diseases, and our students to better understand the needs of the life sciences industry."

This agreement between Merck Serono and EPFL sets a new standard in academic-industrial partnerships. It illustrates the quality of research in Switzerland and also underlines the potential of transdisciplinary projects that bring together expertise and resources in life sciences, basic sciences, information technology and engineering.

The partnership's success will be confirmed through novel therapeutic strategies, academic performance (scientific publications and conferences) and educational opportunities.

####

About Merck Serono
Merck Serono, the new division for innovative small molecules and biopharmaceuticals of Merck, was established following the acquisition of Serono and the integration of its business with the former Merck Ethicals Division. Headquartered in Geneva, Switzerland, Merck Serono discovers, develops, produces and commercializes innovative products to help patients with diseases with unmet needs. Our North American business operates in the United States and Canada under EMD Serono.

Merck Serono has leading brands serving patients with cancer (Erbitux(R)), multiple sclerosis (Rebif(R)), infertility (Gonal-f(R)), metabolic and cardiometabolic disorders (Glucophage(R), Concor(R), Saizen(R), Serostim(R)), as well as psoriasis (Raptiva(R)). With an annual R&D investment of EUR 1bn, we are committed to growing our business in specialist-focused therapeutic areas such as Neurodegenerative Diseases and Oncology, as well as new therapeutic areas potentially arising out of our research and development in Autoimmune and Inflammatory Diseases.

About Merck

Merck is a global pharmaceutical and chemical company with sales of EUR 6.3 billion in 2006, a history that began in 1668, and a future shaped by 30,962 employees in 61 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

For more information, please visit http://www.merckserono.net or http://www.merck.de

About EPFL

EPFL is one of the two Ecoles Polytechniques fédérales in Switzerland. It has three missions: education, research and technology transfer at the highest international level. In its idyllic location on the shores of Lake Geneva, EPFL brings together a campus of more than 10,000 people. It offers 13 complete study programs at the Bachelor's and Master's levels in engineering, basic sciences, computer and communication sciences, life sciences, civil engineering, architecture and the environment. With more than 250 laboratories and research groups on campus, EPFL is one of Europe's most innovative and productive technology institutes.

For more information, please visit http://www.epfl.ch

For more information, please click here

Contacts:
Merck Serono International S.A.
9, chemin des Mines
1202 Geneva
Switzerland
Phone: +41 22 414 3000
Fax: +41 22 731 2179

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Academic/Education

Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015

SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015

CNSE's Smart System Technology & Commercialization Center Successfully Recertifies as ISO 9001:2008 January 12th, 2015

SUNY Poly Now Accepting Applications to the Colleges of Nanoscale Science and Engineering for Fall 2015: Full Scholarships Available to Incoming CNSE Students January 7th, 2015

Nanomedicine

Teijin to Participate in Nano Tech 2015 January 22nd, 2015

2nd International Conference on Infectious Diseases & Nanomedicine (December 15-18, 2015, Kathmandu, NEPAL) January 22nd, 2015

Anti-microbial coatings with a long-term effect for surfaces presentation at nano tech 2015 in Japan January 21st, 2015

A spoonful of sugar in silver nanoparticles to regulate their toxicity January 21st, 2015

Announcements

GS7 Graphene Sensor maybe Solution in Fight Against Cancer January 25th, 2015

Toyocolor to Launch New Carbon Nanotube Materials at nano tech 2015 January 24th, 2015

NANOPOSTER 2015 - 5th Virtual Nanotechnology Conference - call for abstracts January 24th, 2015

Nanosensor Used for Simultaneous Determination of Effective Tea Components January 24th, 2015

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

OCSiAl supports NanoART Imagery Contest January 23rd, 2015

EnvisioNano: An image contest hosted by the National Nanotechnology Initiative (NNI) January 22nd, 2015

Laser-generated surface structures create extremely water-repellent metals: Super-hydrophobic properties could lead to applications in solar panels, sanitation and as rust-free metals January 20th, 2015

NREL Scientist Brian Gregg Named AAAS Fellow: Gregg honored for distinguished contributions to the field of organic solar photoconversion January 20th, 2015

Alliances/Partnerships/Distributorships

Smart keyboard cleans and powers itself -- and can tell who you are January 21st, 2015

DNA 'glue' could someday be used to build tissues, organs January 14th, 2015

GLOBALFOUNDRIES and Linear Dimensions to Offer Joint Analog Solution For Fast-Growing Wearables and MEMs Sensors Markets January 9th, 2015

Nanowire clothing could keep people warm -- without heating everything else January 7th, 2015

Research partnerships

Wearable sensor clears path to long-term EKG, EMG monitoring January 20th, 2015

Graphene enables all-electrical control of energy flow from light emitters: First signatures of graphene plasmons at telecommunications wavelength revealed January 20th, 2015

Charge instability detected across all types of copper-based superconductors: Findings may help researchers synthesize materials that can superconduct at room temperature January 16th, 2015

Gold nanoparticles show promise for early detection of heart attacks: NYU School of Engineering Professors collaborate with researchers from Peking University on a new test strip January 15th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE